Related Experiment Video

Updated: Mar 25, 2026

MeRIP-qPCR Assay for Detecting m6A Modification Levels of Specific RNA in Osteosarcoma Cells
05:16

MeRIP-qPCR Assay for Detecting m6A Modification Levels of Specific RNA in Osteosarcoma Cells

Published on: December 30, 2025

349

microRNA-363 plays a tumor suppressive role in osteosarcoma by directly targeting MAP2K4

Xueqin Li1, Xinsheng Liu1, Jun Fang1

  • 1Department of Orthopaedic Surgery, Yidu Central Hospital of Weifang, Weifang Medical University Qingzhou 262500, Shandong, China.

International Journal of Clinical and Experimental Medicine
|February 18, 2016
PubMed

Insights

MicroRNA-363 is down-regulated in osteosarcoma, inhibiting tumor growth and metastasis. This microRNA (miRNA) targets MAP2K4, suggesting potential therapeutic value for osteosarcoma treatment.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Aberrant microRNA (miRNA) expression is implicated in osteosarcoma pathogenesis.
  • Understanding the role of specific miRNAs, like microRNA-363, is crucial for osteosarcoma research.

Purpose of the Study:

  • To investigate the expression, function, and molecular mechanisms of microRNA-363 in osteosarcoma.
  • To determine the potential of microRNA-363 as a therapeutic target for osteosarcoma.

Main Methods:

  • Quantitative Real-time PCR (qRT-PCR) for microRNA-363 expression analysis.
  • Cellular assays including CCK8, migration, and invasion assays.
  • Western blot and Dual-Luciferase reporter assays for molecular mechanism investigation.

Main Results:

  • MicroRNA-363 expression was significantly down-regulated in osteosarcoma tissues and cell lines.
  • Low microRNA-363 levels correlated with advanced tumor size, clinical stage, and distant metastasis.
  • MicroRNA-363 directly targeted MAP2K4, suppressing osteosarcoma cell proliferation, migration, and invasion.

Conclusions:

  • MicroRNA-363 functions as a tumor suppressor in osteosarcoma by targeting MAP2K4.
  • The findings highlight microRNA-363's potential as a novel therapeutic agent for osteosarcoma.
Keywords:
MAP2K4growthmetastasismicroRNA-363osteosarcoma

More Related Videos

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.8K
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.1K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
MicroRNAs01:22

MicroRNAs

12.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K